Lux BioPure
RESEARCH LIBRARY
Published studies and papers relevant to the peptides we carry. For educational and reference purposes only.
In this 36-week phase 2 trial in adults with type 2 diabetes, the authors reported dose-dependent reductions in HbA1c and body weight versus placebo, with a safety profile consistent with the incretin class (predominantly mild-to-moderate gastrointestinal events).
See full paperIn this 48-week phase 2 trial in adults with obesity, the authors reported mean weight reductions of up to 24.2% at the highest dose versus 2.1% with placebo, with dose-dependent effects and mostly gastrointestinal adverse events.
See full paperThis review summarizes preclinical research on the stable gastric pentadecapeptide BPC 157, reporting cytoprotective and healing effects across gastrointestinal-tract lesion models in animals and noting its stability in human gastric juice.
See full paperIn a rat medial collateral ligament transection model, the authors reported that BPC 157 — given systemically or locally — improved functional, biomechanical, and histological measures of ligament healing versus controls.
See full paperDOI: 10.1002/jor.21107
In rodent wound models, the authors reported that thymosin beta-4 promoted angiogenesis, accelerated dermal wound repair, and stimulated hair-follicle development.
See full paperIn healthy adults, single injections of CJC-1295 produced dose-dependent increases in growth hormone (2- to 10-fold) and IGF-I (1.5- to 3-fold) that persisted for up to 6 or more days, consistent with the compound's long half-life (about 6-8 days).
See full paperDOI: 10.1210/jc.2005-1536
In rodent studies, the authors reported that Semax activated brain dopaminergic and serotoninergic systems, increasing striatal dopamine and serotonin turnover — mechanistic context for its study as a nootropic peptide.
See full paperIn this clinical study of patients at different stages of ischemic stroke, the authors reported that adding Semax to standard therapy was associated with improved neurological outcome measures compared with standard therapy alone.
See full paperAll references are provided for informational purposes only. Lux BioPure does not endorse or validate the claims made in cited studies. Products are for research use only.